Head-to-head · Cost-Efficiency Index
Tell Her Doc vs Nolu
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Tell Her Doc
Cost-first shoppers who want women seeking a well-documented, LegitScript-verified provider -- but get the real recurring price before trusting the $269 headline.
Visit Tell Her DocNolu
Shoppers who want GLP-1 plus an adjacent microdose or NAD+/longevity line without juggling separate accounts.
Visit NoluThe verdict
Tell Her Doc takes it, leading the Cost-Efficiency Index 69 to 68. TellHerDoc is a women's-health-oriented telehealth platform offering compounded and brand-name semaglutide/tirzepatide, backed by four named physicians (with published NPI numbers), four named compounding pharmacies. Nolu still earns a C — Shoppers who want GLP-1 plus an adjacent microdose or NAD+/longevity line without juggling separate accounts.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Tell Her Doc.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Tell Her Doc | Nolu |
|---|---|---|
| Cost-Efficiency Index | 69/100 | 68/100 |
| Semaglutide / mo | $269/mo (compounded oral) | $249 (billed per 4 weeks, ~8% above nominal monthly) |
| Tirzepatide / mo | Not disclosed | $339 (billed per 4 weeks, ~8% above nominal monthly) |
| Semaglutide / yr (modeled) | $3,228 | $2,988 |
| Tirzepatide / yr (modeled) | — | $4,068 |
| Coverage | All 50 states | All 50 states + Washington, D.C. (standard eligibility hedge) |
| Oral / sublingual | Yes | Yes |
| Brand-name access | Yes | Compounded only |
| Rank here | #108 | #111 |
Tell Her Doc
69/100Where the value is
- Four named, NPI-verified physicians -- unusually transparent medical leadership for this category
- Four named compounding pharmacy partners (Belmar, Strive, Epiq Scripts, Casa Pharma Rx)
- Claims and displays coverage across all 50 states
The tradeoffs
- Headline '$269 / $140 off' price is a prepaid, first-time-customer, oral-semaglutide-only promo -- not a general or recurring rate
- No standalone tirzepatide price disclosed
Nolu
68/100Where the value is
- Both molecules published up front — $249 semaglutide, $339 tirzepatide — plus an oral semaglutide tablet option
- All-inclusive per-cycle pricing: consultation, medication and shipping bundled, no separate membership fee
- LegitScript verified
The tradeoffs
- Billed every 4 weeks, not per calendar month — 13 charges a year, not 12, so the real annualized cost runs ~8% above the headline figure
- No named medical director, prescriber, or compounding pharmacy disclosed anywhere on the site
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.